The COVID-19 pandemic illuminated the global risk posed by infectious agents and the need to develop accurate and portable diagnostic tests for pathogen detection. CRISPR-based biosensing technology detects specific nucleic acid sequences in infectious agents and can be used for at home or on field diagnostic tests, providing early surveillance for infectious diseases.
Download this eBook from Drug Discovery News and learn how scientists apply CRISPR technology to develop rapid and sensitive diagnostic tests.